Rhumbline Advisers Abiomed Inc Transaction History

Rhumbline Advisers

$109 Billion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$242.49 - $301.46 $307,477 - $382,251	1,268 Added 1.54%	83,549 $20.5 Million
Q2 2022 Aug 11, 2022	BUY	$224.73 - $338.64 $809,028 - $1.22 Million	3,600 Added 4.58%	82,281 $20.4 Million
Q1 2022 May 12, 2022	SELL	$277.25 - $366.29 $1.09 Million - $1.44 Million	-3,927 Reduced 4.75%	78,681 $26.1 Million
Q4 2021 Feb 10, 2022	SELL	$300.63 - $371.35 $976,145 - $1.21 Million	-3,247 Reduced 3.78%	82,608 $29.7 Million
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $447,604 - $542,856	1,443 Added 1.71%	85,855 $27.9 Million
Q2 2021 Aug 05, 2021	SELL	$262.71 - $351.17 $261,921 - $350,116	-997 Reduced 1.17%	84,412 $26.3 Million
Q1 2021 May 06, 2021	SELL	$285.92 - $355.13 $722,519 - $897,413	-2,527 Reduced 2.87%	85,409 $27.2 Million
Q4 2020 Feb 10, 2021	BUY	$251.88 - $324.2 $205,534 - $264,547	816 Added 0.94%	87,936 $28.5 Million
Q3 2020 Nov 12, 2020	SELL	$255.22 - $317.0 $1.04 Million - $1.29 Million	-4,057 Reduced 4.45%	87,120 $24.1 Million
Q2 2020 Aug 13, 2020	SELL	$141.4 - $257.09 $541,420 - $984,397	-3,829 Reduced 4.03%	91,177 $22 Million
Q1 2020 May 06, 2020	BUY	$130.51 - $196.01 $389,180 - $584,501	2,982 Added 3.24%	95,006 $13.8 Million
Q4 2019 Feb 05, 2020	BUY	$159.31 - $223.54 $887,675 - $1.25 Million	5,572 Added 6.45%	92,024 $15.7 Million
Q3 2019 Oct 23, 2019	BUY	$175.89 - $279.23 $474,551 - $753,362	2,698 Added 3.22%	86,452 $15.4 Million
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $1.13 Million - $1.28 Million	-4,503 Reduced 5.1%	83,754 $21.8 Million
Q1 2019 May 01, 2019	SELL	$276.39 - $362.25 $763,665 - $1 Million	-2,763 Reduced 3.04%	88,257 $25.2 Million
Q4 2018 Jan 31, 2019	BUY	$281.08 - $444.25 $146,161 - $231,010	520 Added 0.57%	91,020 $29.6 Million
Q3 2018 Nov 07, 2018	BUY	$354.53 - $449.75 $397,073 - $503,720	1,120 Added 1.25%	90,500 $40.7 Million
Q2 2018 Aug 06, 2018	SELL	$278.07 - $446.21 $2.28 Million - $3.66 Million	-8,197 Reduced 8.4%	89,380 $36.6 Million
Q1 2018 May 02, 2018	SELL	$192.49 - $295.85 $1.05 Million - $1.62 Million	-5,476 Reduced 5.31%	97,577 $28.4 Million
Q4 2017 Feb 09, 2018	SELL	$168.78 - $199.74 $213,169 - $252,271	-1,263 Reduced 1.21%	103,053 $19.3 Million
Q3 2017 Nov 06, 2017	BUY	$145.39 - $168.6 $15.2 Million - $17.6 Million	104,316	104,316 $17.6 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account